Clinical Trials in Phoenix

Showing 5101-5120 of 16,646 trials

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.

Ovarian CancerClear Cell CarcinomaEndometrial Cancer+2 more

Xencor, Inc.170 participantsStarted Jul 2022

Prescott, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +14 more locations

RECRUITINGNA299 miles

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

NCT06681428

The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.

Diabetic Foot Ulcer (DFU)Chronic Foot Ulcers

Tides Medical240 participantsStarted Nov 2024

Fresno, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +6 more locations

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Find Trials by Condition in Phoenix

A Study of Imvotamab in Severe Systemic Lupus Erythematosus

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Study of SGN-ALPV in Advanced Solid Tumors

Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis